Role of [11C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours

Clinical Neurology and Neurosurgery

Volumn 139, Issue , 2015, Pages 328-333

  Cicuendez, Marta ^a   Lorenzo Bosquet, Carles ^a   Cuberas Borrós, Gemma ^a   Martinez Ricarte, Francisco ^a   Cordero, Esteban ^a   Martinez Saez, Elena ^a   Castell Conesa, Joan ^a   Sahuquillo, Juan ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Brain metastases; Brain tumours; Gliomas; MET PET; Methionine; Positron emission tomography

Indexed keywords

KI 67 ANTIGEN; METHIONINE C 11; CARBON; METHIONINE;

ADULT; ARTICLE; ASTROCYTOMA; BRAIN METASTASIS; BRAIN TUMOR; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; EPENDYMOMA; FEMALE; GLIOBLASTOMA; GLIOMA; HISTOLOGY; HISTOPATHOLOGY; HUMAN; LONG TERM SURVIVAL; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PREDICTION; RETROSPECTIVE STUDY; SURVIVAL TIME; TUMOR GROWTH; ADOLESCENT; AGED; BRAIN NEOPLASMS; GANGLIOGLIOMA; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROGNOSIS; SCINTISCANNING; SECONDARY; SURVIVAL RATE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; EPENDYMOMA; FEMALE; GANGLIOGLIOMA; GLIOBLASTOMA; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; METHIONINE; MIDDLE AGED; OLIGODENDROGLIOMA; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84946903241     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2015.10.035     Document Type: Article

References (44)

1. Q.T. Ostrom, H. Gittleman, P. Farah, A. Ondracek, Y. Chen, Y. Wolinsky, N.E. Stroup, C. Kruchko, and J.S. Barnholtz-Sloan CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010 Neuro Oncol. 15 Suppl. 2 2013 ii1 ii56
2. A.K. Demetriades, A.C. Almeida, R.S. Bhangoo, and S.F. Barrington Applications of positron emission tomography in neuro-oncology: a clinical approach Surg.: J. R. Coll. Surg. Edinb. Irel. 12 2014 148 157
3. D.R. Johnson, and B.P. O'Neill Glioblastoma survival in the United States before and during the temozolomide era J. Neurooncol. 107 2012 359 364
4. S. Mirzaei, P. Knoll, and H. Kohn Diagnosis of recurrent astrocytoma with fludeoxyglucose F18 PET scanning N. Engl. J. Med. 344 2001 2030 2031
5. 11C] Methionine PET, histopathology, and survival in primary brain tumors and recurrence AJNR. Am. J. Neuroradiol. 27 2006 1432 1437
6. D. Ribom, H. Engler, E. Blomquist, and A. Smits Potential significance of (11)C-methionine PET as a marker for the radiosensitivity of low-grade gliomas Eur. J. Nucl. Med. Mol. Imaging 29 2002 632 640
7. N. Tsuyuguchi, T. Takami, I. Sunada, Y. Iwai, K. Yamanaka, K. Tanaka, M. Nishikawa, K. Ohata, K. Torii, M. Morino, A. Nishio, and M. Hara Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery - in malignant glioma Ann. Nucl. Med. 18 2004 291 296
8. B. Pirotte, S. Goldman, S. Salzberg, D. Wikler, P. David, A. Vandesteene, P. Van Bogaert, I. Salmon, J. Brotchi, and M. Levivier Combined positron emission tomography and magnetic resonance imaging for the planning of stereotactic brain biopsies in children: experience in 9 cases Pediatr. Neurosurg. 38 2003 146 155
9. D.D. Langleben, and G.M. Segall PET in differentiation of recurrent brain tumor from radiation injury J. Nucl. Med.: Off. Publ. Soc. Nucl. Med. 41 2000 1861 1867
10. M. Levivier, D. Wikler Jr., N. Massager, P. David, D. Devriendt, J. Lorenzoni, B. Pirotte, F. Desmedt, S. Simon Jr., S. Goldman, P. Van Houtte, and J. Brotchi The integration of metabolic imaging in stereotactic procedures including radiosurgery: a review J. Neurosurg. 97 2002 542 550
11. L.M. DeAngelis Brain tumors N. Engl. J. Med. 344 2001 114 123
12. P.T. Meyer, M. Schreckenberger, U. Spetzger, G.F. Meyer, O. Sabri, K.S. Setani, T. Zeggel, and U. Buell Comparison of visual and ROI-based brain tumour grading using 18F-FDG PET: ROC analyses Eur. J. Nucl. Med. 28 2001 165 174
13. K. Van Laere, S. Ceyssens, F. Van Calenbergh, T. de Groot, J. Menten, P. Flamen, G. Bormans, and L. Mortelmans Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value Eur. J. Nucl. Med. Mol. Imaging 32 2005 39 51
14. K. Herholz, T. Holzer, B. Bauer, R. Schroder, J. Voges, R.I. Ernestus, G. Mendoza, G. Weber-Luxenburger, J. Lottgen, A. Thiel, K. Wienhard, and W.D. Heiss 11C-methionine PET for differential diagnosis of low-grade gliomas Neurology 50 1998 1316 1322
15. B.J. Pirotte, A. Lubansu, N. Massager, D. Wikler, P. Van Bogaert, M. Levivier, J. Brotchi, and S. Goldman Clinical impact of integrating positron emission tomography during surgery in 85 children with brain tumors J. Neurosurg. Pediatr. 5 2010 486 499
16. P.L. Jager, W. Vaalburg, J. Pruim, E.G. de Vries, K.J. Langen, and D.A. Piers Radiolabeled amino acids: basic aspects and clinical applications in oncology J. Nucl. Med.: Off. Publ. Soc. Nucl. Med. 42 2001 432 445
17. N. Sato, M. Suzuki, N. Kuwata, K. Kuroda, T. Wada, T. Beppu, K. Sera, T. Sasaki, and A. Ogawa Evaluation of the malignancy of glioma using 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining Neurosurg. Rev. 22 1999 210 214
18. S. Kim, J.K. Chung, S.H. Im, J.M. Jeong, D.S. Lee, D.G. Kim, H.W. Jung, and M.C. Lee 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET Eur. J. Nucl. Med. Mol. Imaging 32 2005 52 59
19. T. Hatakeyama, N. Kawai, Y. Nishiyama, Y. Yamamoto, Y. Sasakawa, T. Ichikawa, and T. Tamiya 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma Eur. J. Nucl. Med. Mol. Imaging 35 2008 2009 2017
20. 11C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma Eur. J. Nucl. Med. Mol. Imaging 30 2003 868 873
21. D. Ribom, A. Eriksson, M. Hartman, H. Engler, A. Nilsson, B. Langstrom, H. Bolander, M. Bergstrom, and A. Smits Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas Cancer 92 2001 1541 1549
22. C.S. Brock, H. Young, S.M. O'Reilly, J. Matthews, S. Osman, H. Evans, E.S. Newlands, and P.M. Price Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas Br. J. Cancer 82 2000 608 615
23. J.R. Bading, J. Kan-Mitchell, and P.S. Conti System A amino acid transport in cultured human tumor cells: implications for tumor imaging with PET Nucl. Med. Biol. 23 1996 779 786
24. K. Borbely, I. Nyary, M. Toth, K. Ericson, and B. Gulyas Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas J. Neurol. Sci. 246 2006 85 94
25. T. Kato, J. Shinoda, N. Nakayama, K. Miwa, A. Okumura, H. Yano, S. Yoshimura, T. Maruyama, Y. Muragaki, and T. Iwama Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography AJNR. Am. J. Neuroradiol. 29 2008 1176 1182
26. B. Kaschten, A. Stevenaert, B. Sadzot, M. Deprez, C. Degueldre, G. Del Fiore, A. Luxen, and M. Reznik Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine J. Nucl. Med.: Off. Publ. Soc. Nucl. Med. 39 1998 778 785
27. T. Ogawa, F. Shishido, I. Kanno, A. Inugami, H. Fujita, M. Murakami, E. Shimosegawa, H. Ito, J. Hatazawa, T. Okudera, and et al. Cerebral glioma: evaluation with methionine PET Radiology 186 1993 45 53
28. A.W. Glaudemans, R.H. Enting, M.A. Heesters, R.A. Dierckx, R.W. van Rheenen, A.M. Walenkamp, and R.H. Slart Value of 11C-methionine PET in imaging brain tumours and metastases Eur. J. Nucl. Med. Mol. Imaging 40 2013 615 635
29. T. Yamane, S. Sakamoto, and M. Senda Clinical impact of (11)C-methionine PET on expected management of patients with brain neoplasm Eur. J. Nucl. Med. Mol. Imaging 37 2010 685 690
30. A.L. Grosu, S.T. Astner, E. Riedel, C. Nieder, N. Wiedenmann, F. Heinemann, M. Schwaiger, M. Molls, H.J. Wester, and W.A. Weber An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases Int. J. Radiat. Oncol. Biol. Phys. 81 2011 1049 1058
31. W.W. Souba, and A.J. Pacitti How amino acids get into cells: mechanisms, models, menus, and mediators JPEN, J. Parent. Enter. Nutr. 16 1992 569 578
32. S. Goldman, M. Levivier, B. Pirotte, J.M. Brucher, D. Wikler, P. Damhaut, S. Dethy, J. Brotchi, and J. Hildebrand Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy J. Nucl. Med.: Off. Publ. Soc. Nucl. Med. 38 1997 1459 1462
33. T. Saito, T. Maruyama, Y. Muragaki, M. Tanaka, M. Nitta, J. Shinoda, T. Aki, H. Iseki, K. Kurisu, and Y. Okada 11C-methionine uptake correlates with combined 1p and 19q loss of heterozygosity in oligodendroglial tumors AJNR. Am. J. Neuroradiol. 34 2013 85 91
34. J.M. Derlon, M.C. Petit-Taboue, F. Chapon, V. Beaudouin, M.H. Noel, C. Creveuil, P. Courtheoux, and J.P. Houtteville The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine Neurosurgery 40 1997 276 287 (discussion 287-278)
35. F. Kiessling, M. Krix, M. Heilmann, S. Vosseler, M. Lichy, C. Fink, N. Farhan, K. Kleinschmidt, L. Schad, N.E. Fusenig, and S. Delorme Comparing dynamic parameters of tumor vascularization in nude mice revealed by magnetic resonance imaging and contrast-enhanced intermittent power Doppler sonography Investig. Radiol. 38 2003 516 524
36. A. Hilario, A. Ramos, A. Perez-Nunez, E. Salvador, J.M. Millan, A. Lagares, J.M. Sepulveda, P. Gonzalez-Leon, A. Hernandez-Lain, and J.R. Ricoy The added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas AJNR. Am. J. Neuroradiol. 33 2012 701 707
37. R.M. Quencer, and E.A. Neuwelt Advances in the understanding of the blood-brain barrier in neuro-oncology AJNR. Am. J. Neuroradiol. 23 2002 1807 1810
38. L. Bogin, R. Margalit, J. Mispelter, and H. Degani Parametric imaging of tumor perfusion using flow- and permeability-limited tracers J. Magn. Reson. Imaging: JMRI 16 2002 289 299
39. K. Miwa, J. Shinoda, H. Yano, A. Okumura, T. Iwama, T. Nakashima, and N. Sakai Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study J. Neurol. Neurosurg. Psychiatry 75 2004 1457 1462
40. N.F. Marko, R.J. Weil, J.L. Schroeder, F.F. Lang, D. Suki, and R.E. Sawaya Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 32 2014 774 782
41. L. Capelle, D. Fontaine, E. Mandonnet, L. Taillandier, J.L. Golmard, L. Bauchet, J. Pallud, P. Peruzzi, M.H. Baron, M. Kujas, J. Guyotat, R. Guillevin, M. Frenay, S. Taillibert, P. Colin, V. Rigau, F. Vandenbos, C. Pinelli, H. Duffau French Reseau d'Etude des G Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article J. Neurosurg. 118 2013 1157 1168
42. O. De Witte, I. Goldberg, D. Wikler, S. Rorive, P. Damhaut, M. Monclus, I. Salmon, J. Brotchi, and S. Goldman Positron emission tomography with injection of methionine as a prognostic factor in glioma J. Neurosurg. 95 2001 746 750
43. T. Singhal, T.K. Narayanan, M.P. Jacobs, C. Bal, and J.C. Mantil 11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRI J. Nucl. Med.: Off. Publ. Soc. Nucl. Med. 53 2012 1709 1715
44. D.J. Coope, J. Cizek, C. Eggers, S. Vollmar, W.D. Heiss, and K. Herholz Evaluation of primary brain tumors using 11C-methionine PET with reference to a normal methionine uptake map J. Nucl. Med.: Off. Publ. Soc. Nucl. Med. 48 2007 1971 1980